Clinical Trial Update: National Survey on GERD Patients (Adults and Children)

View source ↗

Summary

AstraZeneca-sponsored national survey of adults and children with gastroesophageal reflux disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Snippet

Sponsor: AstraZeneca | Conditions: GERD (Gastroesophageal Reflux Disease) | Status: COMPLETED